Skip to content
HeyJared

Kevin Famuyiro

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Sep 22, 2026
Outlet visibility, for LA Times Business
Top 10K sites
Earliest in this view
Sep 1, 2026

Latest articles

  1. Article · Sep 22, 2026 · Kevin Famuyiro

    Saudi Biotech Summit Reports SAR 5.5 Billion in New Deals (opens the original)

    Excerpt · English

    Read excerpt

    This is read by an automated voice. Please report any issues or inconsistencies here. Get the latest breakthroughs, expert insights and cutting-edge developments in medicine and science from LA Times Studios. By continuing, you agree to our Terms of Service, which include arbitration and a class action waiver. You agree that we and our third-party vendors may collect and use your information, including through cookies, pixels and similar technologies, for the purposes set forth in our Privacy Po

  2. Article · Sep 22, 2026 · Kevin Famuyiro

    23 Biotech Companies Pitch for Funding at Saudi Arabia's LSIF 2026 (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    This is read by an automated voice. Please report any issues or inconsistencies here. The Life Sciences Innovation Forum, known as LSIF, is the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026). This year’s forum brought 23 biotechnology companies from eight countries to Riyadh to pitch investors, judges and leaders of the Kingdom’s life sciences sector, according to organizers. “We were proud to welcome leading investment firms that expressed their willingness t

  3. Article · Sep 1, 2026 · Kevin Famuyiro

    How Clinical Intelligence Eliminates Health Plan Friction (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    This is read by an automated voice. Please report any issues or inconsistencies here. Get the latest breakthroughs, expert insights and cutting-edge developments in medicine and science from LA Times Studios. By continuing, you agree to our Terms of Service, which include arbitration and a class action waiver. You agree that we and our third-party vendors may collect and use your information, including through cookies, pixels and similar technologies, for the purposes set forth in our Privacy Po

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 10K sites

For LA Times Business, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Kevin Famuyiro